(Q38859476)

English

Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries (English)

1 reference

Europe PubMed Central

7 September 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

multidrug-resistant tuberculosis

1 reference

based on heuristic

inferred from title

2

object named as

Anna Vassall

1 reference

Europe PubMed Central

7 September 2017

author name string

Carlos Acuna-Villaorduna

1

1 reference

Europe PubMed Central

7 September 2017

German Henostroza

3

1 reference

Europe PubMed Central

7 September 2017

Carlos Seas

4

1 reference

Europe PubMed Central

7 September 2017

Humberto Guerra

5

1 reference

Europe PubMed Central

7 September 2017

Lucy Vasquez

6

1 reference

Europe PubMed Central

7 September 2017

Nora Morcillo

7

1 reference

Europe PubMed Central

7 September 2017

Juan Saravia

8

1 reference

Europe PubMed Central

7 September 2017

Richard O'Brien

9

1 reference

Europe PubMed Central

7 September 2017

Mark D Perkins

10

1 reference

Europe PubMed Central

7 September 2017

Jane Cunningham

11

1 reference

Europe PubMed Central

7 September 2017

Luis Llanos-Zavalaga

12

1 reference

Europe PubMed Central

7 September 2017

Eduardo Gotuzzo

13

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

1 August 2008

1 reference

Europe PubMed Central

7 September 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

7 September 2017

47

1 reference

Europe PubMed Central

7 September 2017

4

1 reference

Europe PubMed Central

7 September 2017

487-495

1 reference

Europe PubMed Central

7 September 2017

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

The treatment of multidrug-resistant tuberculosis in Turkey

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

A cost-benefit analysis of BCG revaccination in the Czech Republic

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Effect of drug resistance on the generation of secondary cases of tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Tuberculosis elimination in the Netherlands

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of mul

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Predictive model to identify positive tuberculosis skin test results during contact investigations.

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Cost effectiveness analysis of strategies for tuberculosis control in developing countries

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Delay in the diagnosis of pulmonary tuberculosis, London, 1998-2000: analysis of surveillance data

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Management of tuberculosis in the United States

1 reference

https://api.crossref.org/works/10.1086%2F590010

21 January 2018

Identifiers

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38859476&oldid=2076052784"